Answers are grounded in this paper and cite their sources.
Patients with PIDD on home IVIG versus SCIG have similar composite health-related quality of life scores as measured by the SF-36. Patients with primary immune-deficiency on home IVIG versus SCIG have similar composite health-related quality of life scores as measured by the SF-36. Personal preferences are important in deciding whether to treat with IVIG or SCIG.
No takes yet. Share an insight, caveat, or question.
Anterasian et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: